Clinical trial
Neurovascular Product Surveillance Registry (INSPIRE) Pipeline™ Flex Embolization Device With Shield Technology™ Post Approval Study (PAS)
NCT05071963 is registered in ClinicalTrials.gov with Medtronic Neurovascular Clinical Affairs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurovascular Product Surveillance Registry (INSPIRE) Pipeline™ Flex Embolization Device With Shield Technology™ Post Approval Study (PAS)
- Lead sponsor
- Medtronic Neurovascular Clinical Affairs
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- December 20, 2021
- Completion date
- April 30, 2028
- Enrollment
- 246 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.